Thymosin Alpha-1: Peptide Research, Mechanisms & Preclinical Findings

For laboratory and research use only. Not for human consumption.

Thymosin Alpha-1 (Tα1) is a 28-residue peptide. In experimental dendritic-cell models, Romani et al. reported tryptophan catabolism through a pathway involving TLR9 and MyD88. This is not evidence of direct binding to TLR2 or TLR9.

Chemical Identity

Twenty-eight residues. Acetylated serine at the N-terminus. Derived from prothymosin alpha : a larger 109-amino acid precursor that thymic epithelial cells chop up and release into circulation.

• Sequence: Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
• Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅
• Molecular Weight: 3,108.3 g/mol
• CAS: 62304-98-7

Heavily acidic : loaded with aspartate and glutamate residues. Net negative charge at physiological pH. Same family name. Entirely different biology.

Discovery Story

1960s. Allan Goldstein and Abraham White at Albert Einstein College of Medicine. They’re studying why the thymus gland matters for immune development.

Ten years of purification work later, 1977: they pull out one specific 28-amino acid peptide from that fraction. Thymosin alpha-1. First individual peptide isolated from the thymic mixture that kept its immunological punch. The sequence got mapped. Production in rat thymus was confirmed (Hannappel & Huff, 1984; Proc Natl Acad Sci USA 81:1008-1011).

Mechanism of Action

TLR9-Dependent Findings in Dendritic Cells

Romani et al. (2006) examined human and murine dendritic-cell models and reported IDO expression and function in murine dendritic cells.

In the murine dendritic-cell experiments, IDO activation required TLR9 and type I interferon receptor signaling. The study reported IL-10 production and generation of regulatory T cells.

The study does not establish direct binding of Tα1 to TLR2 or TLR9, or amplification of one receptor pathway by the other (Romani et al., 2006).

Dendritic-Cell Tryptophan Catabolism

Romani et al. reported induction of indoleamine 2,3-dioxygenase (IDO), an enzyme involved in tryptophan catabolism, in murine dendritic cells. These findings describe the experimental systems evaluated, not a general enhancement of immune function.

Different immunomodulatory angle: KPV peptide works through alpha-MSH receptors instead.

Cytokine Profile

Romani et al. reported IL-10 production in the studied dendritic-cell system. This model-specific finding does not establish a universal cytokine profile.

Regulatory Context

This page describes laboratory research material, not an approved medicinal product.

Preclinical Data

Hepatitis B

Multiple research groups have examined thymalfasin in HBV models : Chien et al. (1998), Mutchnick et al. (1999), Zavaglia et al. (2000) : with varying designs and endpoint measurements.

Thymosin Alpha-1 and Full-Length Thymosin β4

“Thymosin” is in both names. That’s where the overlap stops.

Tα1: 28 amino acids, 3,108 g/mol.

Full-length thymosin β4 is a 43-residue peptide. The Loti Labs TB-500 profile also distinguishes a separate fragment associated with that label.

Same family. Completely different biology.

Safety Profile

• Standard peptide storage requirements : temperature and handling matter for bioactivity

Research-Use Status

Loti Labs materials described here are for laboratory research use only, not for human consumption.

Research Availability

From Loti Labs:

• Thymosin Alpha-1 10mg : $79.99

Conclusion

For a peptide that’s been studied since 1977 and is still generating new mechanistic insights, Tα1 has staying power that most research compounds don’t.

For laboratory and research use only. Not for human consumption.

References

1. Goldstein AL. History of the discovery of the thymosins. Ann N Y Acad Sci. 2007;1112:1-13. PMID: 17468229
2. Romani L, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood. 2006;108(7):2265-2274. doi:10.1182/blood-2006-02-004762. PMID: 16741252
3. Hannappel E, Huff T. Thymosins: prothymosin alpha, parathymosin, and beta-thymosins. Vitam Horm. 2003;66:257-296. PMID: 12852258
4. Baumann CA, et al. Tα1 antagonizes dexamethasone-induced apoptosis of murine thymocytes. Int J Immunopharmacol. 2000;22(12):1057-1066. PMID: 11137614
5. Garaci E, et al. Expert Opin Biol Ther. 2015;15(Suppl 1):S31-S39. PMID: 26096835
6. Costantini C, et al. Reappraisal of thymosin alpha 1 in cancer research. Front Oncol. 2019;9:873. PMID: 31572680
7. Billich A. Thymosin alpha 1 : SciClone Pharmaceuticals. Curr Opin Investig Drugs. 2002;3(5):698-707. PMID: 12090542
8. Armutcu F, et al. Tα1 attenuates lipid peroxidation in fructose-induced steatohepatitis. Clin Biochem. 2005;38(6):540-547.
9. Yang X, et al. Effect of Tα1 on Th1, Th2, Th17, and Treg subpopulations in vitro. Braz J Med Biol Res. 2012;45(1):25-32.
10. Giuliani C, et al. Tα1 regulates MHC class I expression at transcriptional level. Eur J Immunol. 2000;30(3):778-786.
11. FDA. Thymosin Alpha-1 Related Bulk Drug Substances. Office of Pharmaceutical Quality Assessment II. 2024.
12. Chien RN, et al. Hepatology. 1998;27(5):1383-1387. PMID: 9581696